1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yang T, Kong B, Kuang Y, Cheng L, Gu J,
Zhang J, Shu H, Yu S, Yang X, Cheng J, et al: Emodin plays an
interventional role in epileptic rats via multidrug resistance gene
1 (MDR1). Int J Clin Exp Pathol. 8:3418–3425. 2015.PubMed/NCBI
|
3
|
Ma H, Cheng L, Hao K, Li Y, Song X, Zhou H
and Jia L: Reversal effect of ST6GAL 1 on multidrug resistance in
human leukemia by regulating the PI3K/Akt pathway and the
expression of P-gp and MRP1. PLoS One. 9:e851132014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zheng Z, Liu B and Wu X: RhoGDI2
up-regulates P-glycoprotein expression via Rac1 in gastric cancer
cells. Cancer Cell Int. 15:412015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhao J, Liu Y, Huang G, Cui P, Zhang W and
Zhang Y: Long non-coding RNAs in gastric cancer: Versatile
mechanisms and potential for clinical translation. Am J Cancer Res.
5:907–927. 2015.PubMed/NCBI
|
6
|
Du Z, Fei T, Verhaak RG, Su Z, Zhang Y,
Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal
clinically relevant long noncoding RNAs in human cancer. Nat Struct
Mol Biol. 20:908–913. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Autuoro JM, Pirnie SP and Carmichael GG:
Long noncoding RNAs in imprinting and X chromosome inactivation.
Biomolecules. 4:76–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ghosal S, Das S and Chakrabarti J: Long
noncoding RNAs: New players in the molecular mechanism for
maintenance and differentiation of pluripotent stem cells. Stem
Cells Dev. 22:2240–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ounzain S, Pezzuto I, Micheletti R, Burdet
F, Sheta R, Nemir M, Gonzales C, Sarre A, Alexanian M, Blow MJ, et
al: Functional importance of cardiac enhancer-associated noncoding
RNAs in heart development and disease. J Mol Cell Cardiol.
76:55–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Serviss JT, Johnsson P and Grandér D: An
emerging role for long non-coding RNAs in cancer metastasis. Front
Genet. 5:2342014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Popov N and Gil J: Epigenetic regulation
of the INK4b-ARF-INK4a locus: In sickness and in health.
Epigenetics. 5:685–690. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pasmant E, Laurendeau I, Héron D, Vidaud
M, Vidaud D and Bièche I: Characterization of a germ-line deletion,
including the entire INK4/ARF locus, in a melanoma-neural system
tumor family: Identification of ANRIL, an antisense noncoding RNA
whose expression coclusters with ARF. Cancer Res. 67:3963–3969.
2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Aguilo F, Zhou MM and Walsh MJ: Long
noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a
expression. Cancer Res. 71:5365–5369. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Pasmant E, Sabbagh A, Masliah-Planchon J,
Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K,
Valeyrie-Allanore L, et al: NF France Network: Role of noncoding
RNA ANRIL in genesis of plexiform neurofibromas in
neurofibromatosis type 1. J Natl Cancer Inst. 103:1713–1722. 2011.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Özgür E, Mert U, Isin M, Okutan M, Dalay N
and Gezer U: Differential expression of long non-coding RNAs during
genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clin
Exp Med. 13:119–126. 2013. View Article : Google Scholar
|
17
|
Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang
M, Wang CJ, Cao H and Xu J: HOTAIR long noncoding RNA promotes
gastric cancer metastasis through suppression of poly r(C)-binding
protein (PCBP) 1. Mol Cancer Ther. 14:1162–1170. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kong R, Zhang EB, Yin DD, You LH, Xu TP,
Chen WM, Xia R, Wan L, Sun M, Wang ZX, et al: Long noncoding RNA
PVT1 indicates a poor prognosis of gastric cancer and promotes cell
proliferation through epigenetically regulating p15 and p16. Mol
Cancer. 14:822015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Verstraelen J and Reichl S: Multidrug
resistance-associated protein (MRP1, 2, 4 and 5) expression in
human corneal cell culture models and animal corneal tissue. Mol
Pharm. 11:2160–2171. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
He T, Mo A, Zhang K and Liu L: ABCB1/MDR1
gene polymorphism and colorectal cancer risk: A meta-analysis of
case-control studies. Colorectal Dis. 15:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Lo YL and Liu Y: Reversing multidrug
resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and
BCL-2/BCL-xL using liposomal antisense oligonucleotides. PLoS One.
9:e901802014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wang TH, Wan JY, Gong X, Li HZ and Cheng
Y: Tetrandrine enhances cytotoxicity of cisplatin in human
drug-resistant esophageal squamous carcinoma cells by inhibition of
multidrug resistance-associated protein 1. Oncol Rep. 28:1681–1686.
2012.PubMed/NCBI
|
24
|
Zheng G, Peng F, Ding R, Yu Y, Ouyang Y,
Chen Z, Xiao Z and He Z: Identification of proteins responsible for
the multiple drug resistance in 5-fluorouracil-induced breast
cancer cell using proteomics analysis. J Cancer Res Clin Oncol.
136:1477–1488. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhang XW, Bu P, Liu L, Zhang XZ and Li J:
Overexpression of long non-coding RNA PVT1 in gastric cancer cells
promotes the development of multidrug resistance. Biochem Biophys
Res Commun. 462:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wang Y, Zhang D, Wu K, Zhao Q, Nie Y and
Fan D: Long noncoding RNA MRUL promotes ABCB1 expression in
multidrug-resistant gastric cancer cell sublines. Mol Cell Biol.
34:3182–3193. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Jiang M, Huang O, Xie Z, Wu S, Zhang X,
Shen A, Liu H, Chen X, Wu J, Lou Y, et al: A novel long non-coding
RNA-ARA: Adriamycin resistance-associated. Biochem Pharmacol.
87:254–283. 2014. View Article : Google Scholar
|
29
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15(INK4B)
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar
|
31
|
Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY
and Hua KQ: Long non-coding RNA ANRIL predicts poor prognosis and
promotes invasion/metastasis in serous ovarian cancer. Int J Oncol.
46:2497–2505. 2015.PubMed/NCBI
|
32
|
Lin L, Gu ZT, Chen WH and Cao KJ:
Increased expression of the long non-coding RNA ANRIL promotes lung
cancer cell metastasis and correlates with poor prognosis. Diagn
Pathol. 10:142015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Huang MD, Chen WM, Qi FZ, Xia R, Sun M, Xu
TP, Yin L, Zhang EB, De W and Shu YQ: Long non-coding RNA ANRIL is
upregulated in hepatocellular carcinoma and regulates cell
apoptosis by epigenetic silencing of KLF2. J Hematol oncol.
8:502015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W, et al: Long noncoding RNA ANRIL
indicates a poor prognosis of gastric cancer and promotes tumor
growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget.
5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|